Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01706770 · ClinicalTrials.gov registry record · NA
Evaluation of Enfilcon A Soft Contact Lens When Compared to Galyfilcon A Soft Contact Lens
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01706770 is a NA study that has completed, run by CooperVision. The registered enrollment target is 50 participants.
The verdict
NCT01706770, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The primary objective of thes study is to confirm that the ocular response to the Test lenses are similar to those of the Control lenses when used in a 1 week planned replacement, daily wear modality over a 1-month period.
Interventions
- DEVICE enfilcon A
- DEVICE galyfilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01706770
The ClinicalTrials.gov registry entry for NCT01706770 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which enfilcon A is the first listed.
NCT01706770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01706770 about?
NCT01706770 is a clinical study titled "Evaluation of Enfilcon A Soft Contact Lens When Compared to Galyfilcon A Soft Contact Lens". The primary objective of thes study is to confirm that the ocular response to the Test lenses are similar to those of the Control lenses when used in a 1 week planned replacement, daily wear modality over a 1-month period.
What is the current status of trial NCT01706770?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2012-05. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01706770?
The interventions under investigation include: enfilcon A (DEVICE), galyfilcon A (DEVICE).
Who is sponsoring clinical trial NCT01706770?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.